**Author details**

Minoru Tomizawa1\*, Fuminobu Shinozaki2 , Yasufumi Motoyoshi3 , Takao Sugiyama4 , Shigenori Yamamoto5 and Makoto Sueishi4

\*Address all correspondence to: nihminor-cib@umin.ac.jp

1 Department of Gastroenterology, National Hospital Organization Shimoshizu Hospital, Yotsukaido City, Japan

[5] Okita K, Ichisaka T, Yamanaka S. Generation of germline-competent induced pluri‐

Hepatocyte Selection Medium http://dx.doi.org/10.5772/58394 175

[6] Tomizawa M, Shinozaki F, Sugiyama T, Yamamoto S, Sueishi M, Yoshida T. Survival of primary human hepatocytes and death of induced pluripotent stem cells in media

[7] Kooreman NG, Wu JC. Tumorigenicity of pluripotent stem cells: biological insights

[8] Yamamoto H, Quinn G, Asari A, Yamanokuchi H, Teratani T, Terada M, Ochiya T. Differentiation of embryonic stem cells into hepatocytes: biological functions and

[9] Tanaka M, Okabe M, Suzuki K, Kamiya Y, Tsukahara Y, Saito S, Miyajima A. Mouse hepatoblasts at distinct developmental stages are characterized by expression of Ep‐ CAM and DLK1: drastic change of EpCAM expression during liver development.

[10] Leffert HL, Paul D. Studies on primary cultures of differentiated fetal liver cells. J

[11] Matsumoto K, Yamada K, Kohmura E, Kinoshita A, Hayakawa T. Role of pyruvate in ischaemia-like conditions on cultured neurons. Neurol Res 1994;16(6):460-4. [12] Phillips JW, Jones ME, Berry MN. Implications of the simultaneous occurrence of hepatic glycolysis from glucose and gluconeogenesis from glycerol. Eur J Biochem

[13] Sumida KD, Crandall SC, Chadha PL, Qureshi T. Hepatic gluconeogenic capacity from various precursors in young versus old rats. Metabolism 2002;51(7):876-80. [14] Tomizawa M, Toyama Y, Ito C, Toshimori K, Iwase K, Takiguchi M, Saisho H, Yoko‐ suka O. Hepatoblast-like cells enriched from mouse embryonic stem cells in medium without glucose, pyruvate, arginine, and tyrosine. Cell Tissue Res 2008;333(1):17-27.

[15] Pierce GB, Jr., Dixon FJ, Jr., Verney EL. Teratocarcinogenic and tissue-forming poten‐ tials of the cell types comprising neoplastic embryoid bodies. Lab Invest

[16] Teramoto K, Hara Y, Kumashiro Y, Chinzei R, Tanaka Y, Shimizu-Saito K, Asahina K, Teraoka H, Arii S. Teratoma formation and hepatocyte differentiation in mouse liver transplanted with mouse embryonic stem cell-derived embryoid bodies. Trans‐

[17] Miura K, Okada Y, Aoi T, Okada A, Takahashi K, Okita K, Nakagawa M, Koyanagi M, Tanabe K, Ohnuki M, Ogawa D, Ikeda E, Okano H, Yamanaka S. Variation in the

safety of induced pluripotent stem cell lines. Nat Biotechnol 2009;27(8):743-5. [18] Fusaki N, Ban H, Nishiyama A, Saeki K, Hasegawa M. Efficient induction of trans‐ gene-free human pluripotent stem cells using a vector based on Sendai virus, an

potent stem cells. Nature 2007;448(7151):313-7.

lacking glucose and arginine. PLoS One 2013;8(8):e71897.

therapeutic application. Hepatology 2003;37(5):983-93.

Mech Dev 2009;126(8-9):665-76.

Cell Biol 1972;52(3):559-68.

2002;269(3):792-7.

1960;9(583-602.

plant Proc 2005;37(1):285-6.

from molecular imaging. J R Soc Interface 2010;7 Suppl 6(S753-63.

2 Department of Radiology, National Hospital Organization Shimoshizu Hospital, Yotsukaido City, Japan

3 Department of Neurology, National Hospital Organization Shimoshizu Hospital, Yotsukaido City, Japan

4 Department of Rheumatology, National Hospital Organization Shimoshizu Hospital, Yotsukaido City, Japan

5 Department of Pediatrics, National Hospital Organization Shimoshizu Hospital, Yotsukaido City, Japan
